Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents

AIM: To evaluate the outcomes in biological treatment and quality of life of psoriatic patients with chronic hepatitis C (CHC) treated with new Direct-Acting Antiviral agents (DAAs) compared to pegylated interferon-2α plus ribavirin (P/R) therapy. METHODS: This is a retrospective study involving pso...

Descripción completa

Detalles Bibliográficos
Autores principales: Damiani, Giovanni, Franchi, Chiara, Pigatto, Paolo, Altomare, Andrea, Pacifico, Alessia, Petrou, Stephen, Leone, Sebastiano, Pace, Maria Caterina, Fiore, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Observational Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838451/
https://www.ncbi.nlm.nih.gov/pubmed/29527268
http://dx.doi.org/10.4254/wjh.v10.i2.329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838451/
https://www.ncbi.nlm.nih.gov/pubmed/29527268
http://dx.doi.org/10.4254/wjh.v10.i2.329

Ejemplares similares